Care Delivery

This channel includes news on cardiovascular care delivery, including how patients are diagnosed and treated, cardiac care guidelines, policies or legislation impacting patient care, device recalls that may impact patient care, and cardiology practice management.

Conifer, Welldoc partner in digital health app

Conifer Health Solutions, a revenue cycle and value-based care solution provider, has teamed up with Welldoc to launch a new digital health app, Conifer Connect.

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

Global healthcare partnership targets ‘the big catch-up’ vaccination initiative

The initiative aims to reverse the declining trend in childhood vaccination that has been recorded in more than 100 countries since the start of the COVID-19 pandemic.

Thumbnail

Supreme Court upholds full access to abortion pill

The Supreme Court issued a stay on April 21 that keeps mifepristone on the market without restrictions––for now.

Infusion system recalled for possible leaks after multiple complaints

The recall includes more than 1,500 devices distributed to customers from October 2021 to January 2023. 

Thumbnail

OTC Narcan will cost less than $50

The drug's manufacturer said it is working with retailers to get the drug on U.S. shelves and online for purchase by late summer.

bullish investments in healthcare AI

What healthcare AI investors have been saying at HIMSS23

If great power obligates its wielder to exercise great responsibility, those advancing AI in healthcare are up to their necks in duty.

Thumbnail

Supreme Court delays final decision on abortion pill for 2 more days

A common abortion pill, mifepristone, is still in grave danger of being pulled off the market. 

COVID-19 vaccine vaccination myocarditis heart damage inflammation RSNA imaging radiology cardiology

FDA announces shift to simplify COVID-19 vaccines

The recommendation updates the FDA’s emergency use authorizations for the Moderna and Pfizer-BioNTech COVID-19 vaccines.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.